November 20: GILD offers $23.00/share
January 25: GILDoffers $31.00/share plus a CVR of up to $2.50/share
January 30: GILD offers $32.50/share,January 31: CBAY ask...查看全文
Cymabay Therapeutics(CBAY)03-23 04:45
$Cymabay Therapeutics(CBAY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-24-075358 Act: 33 Size: 36 KB 网页链接查看全文
Cymabay Therapeutics(CBAY)03-23 04:55
$Cymabay Therapeutics(CBAY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-24-075399 Act: 33 Size: 36 KB 网页链接查看全文
Cymabay Therapeutics(CBAY)03-23 04:55
$Cymabay Therapeutics(CBAY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-24-075382 Act: 33 Size: 36 KB 网页链接查看全文
Cymabay Therapeutics(CBAY)03-23 05:05
$Cymabay Therapeutics(CBAY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-24-075403 Act: 33 Size: 36 KB 网页链接查看全文
Cymabay Therapeutics(CBAY)02-29 05:45
$Cymabay Therapeutics(CBAY)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001193125-24-050758 Act: 34 Size: 11 MB 网页链接查看全文
Cymabay Therapeutics(CBAY)02-29 06:15
$Cymabay Therapeutics(CBAY)$ SC 14D9/A [Amend] Solicitation, recommendation statements Accession Number: 0001193125-24-050789 Act: 34 Size: 91 KB 网页链接查看全文
Cymabay Therapeutics(CBAY)02-29 06:35
$Cymabay Therapeutics(CBAY)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-24-028791 Act: 34 Size: 40 KB 网页链接查看全文
Cymabay Therapeutics(CBAY)02-15 05:15
$Cymabay Therapeutics(CBAY)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-24-006622 Act: 34 Size: 77 KB 网页链接查看全文
美股滚雪球02-27 11:25
并购要趁早,不然股价涨上来了,要价就高了,比如$吉利德科学(GILD)$ 与$Cymabay Therapeutics(CBAY)$ :
November 20: GILD offers $23.00/share
January 25: GILDoffers $31.00/share plus a CVR of up to $2.50/share
January 30: GILD offers $32.50/share,January 31: CBAY ask...查看全文
chuminhua2023-09-08 21:39
9/7,CymaBay Therapeutics $Cymabay Therapeutics(CBAY)$ 的股价周四上涨了 23%,此前该公司报告其在研药物 seladelpar 在原发性胆汁性胆管炎 (PBC) 患者的 III 期研究中实现了主要目标。 该公司表示,RESPONSE 试验数据支持该产品向美国和欧洲监管机构提交上市申请。
RESPONSE 研究将 193 名...查看全文
不入流资讯2023-09-07 20:50
$Cymabay Therapeutics(CBAY)$ CymaBay Therapeutics jumps 25% premarket as its Seladelpar achieved high statistical significance for the primary and key secondary endpoints in the phase 3 response trial查看全文
产业链观察2023-09-07 19:54
#药闻简讯# 2023年9月7日, -- 专注于为肝病和其他慢性疾病患者提供创新疗法的生物制药公司$Cymabay Therapeutics(CBAY)$ 宣布其研究评估了seladelpar的安全性和有效性,seladelpar是一种强效、选择性、口服活性delpar或PPARδ激动剂,正在开发用于治疗成年原发性胆汁性胆管炎(PBC)患者。该注册...查看全文
产业链观察2023-01-09 04:08
#药闻简讯# 2023年1月8日,$Cymabay Therapeutics(CBAY)$ 今天宣布,已经与Kaken Pharmaceutical Co.("Kaken")达成合作和许可协议,在日本开发和商业化CymaBay的研究性药物seladelpar,用于治疗原发性胆汁性胆管炎("PBC")。
根据协议条款,Kaken获得了在日本开发、商业化和...查看全文
薛定锷之猫2022-08-03 10:17
$Cymabay Therapeutics(CBAY)$ 几个疑问:
1、Seladelpar 的专利到什么时候? 网上搜到说到2035
2、BLACKROCK减仓?还是变更持有人?
3、运营cash不够,面临增发:时机是等file BLA?
4、成交量不够大,与历史相比
看来是潜在候选,但这个2期临床失败怎么回事,还得做功课:ht...查看全文
美股滚雪球2021-10-08 13:06
$Cymabay Therapeutics(CBAY)$ 一家治疗肝脏疾病和慢性病的公司,主要候选药物 seladelpar 正在研究几种主要肝脏疾病的治疗,包括原发性胆汁性胆管炎 (PBC)、非酒精性脂肪性肝炎和原发性硬化性胆管炎。
Seladelpar 是一种口服给药的选择性 PPARdelta 激动剂,获得了FDA的突破性疗法认定和EMEA...查看全文
$Cymabay Therapeutics(CBAY)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-24-075232 Act: 33 Size: 25 KB 网页链接
$Cymabay Therapeutics(CBAY)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-24-000200 Act: 34 Size: 3 KB 网页链接
$Cymabay Therapeutics(CBAY)$ 8-K Current report, items 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-24-074701 Act: 34 Size: 246 KB 网页链接
$Cymabay Therapeutics(CBAY)$ SC 14D9/A [Amend] Solicitation, recommendation statements Accession Number: 0001193125-24-074582 Act: 34 Size: 17 KB 网页链接
$Cymabay Therapeutics(CBAY)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-24-037575 Act: 34 Size: 39 KB 网页链接
$Cymabay Therapeutics(CBAY)$ SC 14D9/A [Amend] Solicitation, recommendation statements Accession Number: 0001193125-24-072737 Act: 34 Size: 16 KB 网页链接
$Cymabay Therapeutics(CBAY)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-24-072728 Act: 34 Size: 140 KB 网页链接
$Cymabay Therapeutics(CBAY)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-24-036695 Act: 34 Size: 41 KB 网页链接
$Cymabay Therapeutics(CBAY)$ SC 14D9/A [Amend] Solicitation, recommendation statements Accession Number: 0001193125-24-069145 Act: 34 Size: 157 KB 网页链接
$Cymabay Therapeutics(CBAY)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-24-034997 Act: 34 Size: 46 KB 网页链接